Advertisement

Related Videos

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Opportunities to Optimize Cancer Policies Panel Discussion

Advertisement

Advertisement




Jul
08
Today In Oncology
GLP-1 Receptor Agonists Linked to Lower Colorectal Cancer Risk in Patients With IBD
Intraoperative Margin Assessment With Specimen PET/CT Imaging in Early Breast Cancer
No Survival Benefit From Chemoradiotherapy After D2 Gastrectomy in Gastric Cancer
All-Oral Combination of Revumenib, Decitabine/Cedazuridine, and Venetoclax for Relapsed or Refractory AML
Investigators Identify Resistance Mechanism to Tagraxofusp Among Patients With BPDCN
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo